Which has grown faster, BBIO or DVA?

Over the past five years, BBIO grew revenue faster — BBIO at a 62.61% CAGR versus DVA at 3.91%.

Is BBIO or DVA more profitable?

DVA runs the higher net margin — BBIO at -97.64% versus DVA at 6.05%.

How have BBIO and DVA total returns compared?

Over the past 5 years, BBIO delivered 7.38% and DVA delivered 9.22% annualized total return. Past performance doesn't predict future results.

BridgeBio Pharma, Inc. (BBIO) vs DaVita Inc. (DVA)

A side-by-side comparison of BridgeBio Pharma, Inc. and DaVita Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BBIO

BridgeBio Pharma, Inc.

$12.95B

$66.14HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

DVA

DaVita Inc.

$11.47B

$178.72HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BBIO vs DVA

growth of $100 · dividends reinvested · last 7y

BBIO +140.1% (+13.3%/yr)DVA +229.3% (+18.6%/yr)DVA compounded faster over this window

BBIO DVA

BBIO vs DVA: by the numbers

•BBIO is the larger company ($12.95B vs $11.47B market cap).
•DVA is profitable (6.05% net margin) while BBIO runs a net loss (-97.64%).
•BBIO grew revenue faster over the past five years (62.61% vs 3.91% CAGR).

Metrics side by side

Valuation

Metric	BBIO	DVA
P/E ratio	N/A	15.70
Forward P/E	N/A	12.10
PEG ratio	N/A	1.90
P/S ratio	18.17	0.82
EV / EBITDA	N/A	7.66
FCF yield	N/A	14.03%

Profitability

Metric	BBIO	DVA
Gross margin	93.35%	31.02%
Operating margin	-113.35%	15.06%
Net margin	-97.64%	6.05%
ROIC	-62.14%	11.18%

Growth (annualized)

Metric	BBIO	DVA
Revenue CAGR (5Y)	62.61%	3.91%
EPS CAGR (5Y)	N/A	8.25%
FCF CAGR (5Y)	N/A	7.44%
Total return CAGR (5Y)	7.38%	9.22%

Frequently asked

Which has grown faster, BBIO or DVA?: Over the past five years, BBIO grew revenue faster — BBIO at a 62.61% CAGR versus DVA at 3.91%.
Is BBIO or DVA more profitable?: DVA runs the higher net margin — BBIO at -97.64% versus DVA at 6.05%.
How have BBIO and DVA total returns compared?: Over the past 5 years, BBIO delivered 7.38% and DVA delivered 9.22% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BBIO analysis Full DVA analysis Interactive comparison tool

Dig into the metrics

DaVita P/E ratio BridgeBio Pharma ROE DaVita ROE BridgeBio Pharma operating margin DaVita operating margin BridgeBio Pharma revenue growth DaVita revenue growth BridgeBio Pharma free cash flow DaVita free cash flow

BridgeBio Pharma & DaVita appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.